Renaissance Capital logo

FRTA News

US IPO Weekly Recap: Two deals flounder while one soars

FRTA

Three IPOs raised $495 million this week, led by iRhythm Technologies (IRTC), which popped 53% on its first day. The other two IPOs, CRISPR Therapeutics (CRSP) and Forterra (FRTA), priced below the range and closed the week down 1% and 6%, respectively. Forterra’s 8% drop on its first day was the eighth worst...read more

Forterra prices IPO below the range at $18

FRTA

Forterra, which is a leading drainage and potable water pipe company in the US and Eastern Canada, raised $332 million by offering 18.4 million shares at $18, below the range of $19 to $21. Forterra plans to list on the Nasdaq under the symbol FRTA. Goldman Sachs, Citi, Credit Suisse, Barclays, Deutsche Bank and RBC Capital Markets acted as lead managers on the deal....read more

US IPO Week Ahead: 3 IPOs feature industrial pipes and high-growth health care

FRTA

Three IPOs are set to raise $518 million in the week ahead. LBO'd industrial pipe maker Forterra is by far the week's largest deal, while CRISPR Therapeutics will attempt to prove that gene editing is more than a pipe dream. High-growth heart monitoring company iRhythm Technologies plans to raise $75 million. A fourth deal, Full Spectrum, is still exploring its $15 million IPO on a...read more

Ceci n'est une pipe IPO: Forterra sets terms for $368 million US offering

FRTA

Forterra, a US manufacturer of concrete and iron pipes used for drainage and water transmission, announced terms for its IPO on Friday. The Irving, TX-based company plans to raise $368 million by offering 18.4 million shares at a price range of $19 to $21. At the midpoint of the proposed range, Forterra would command a market value of $1.3 billion. Forterra was founded in...read more